Average Co-Inventor Count = 5.37
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Millennium Pharmaceuticals Limited (15 from 850 patents)
2. Merck + Co., Inc. (14 from 4,770 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Millenium Pharmaceuticals, Inc. (2 from 36 patents)
5. Ore Pharmaceuticals Inc. (1 from 4 patents)
34 patents:
1. 11014928 - Compounds and methods for inhibiting mitotic progression
2. 10836766 - Aurora kinase inhibitors for inhibiting mitotic progression
3. 10414770 - Compounds and methods for inhibiting mitotic progression
4. 9988384 - Aurora kinase inhibitors for inhibiting mitotic progression
5. 9765076 - Aurora kinase inhibitors for inhibiting mitotic progression
6. 9765078 - Compounds and methods for inhibiting mitotic progression
7. 9718788 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes
8. 9458108 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes
9. 9150525 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes
10. 9102678 - Compounds and methods for inhibiting mitotic progression
11. 8481550 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12. 8338449 - Isoquinolinone potassium channel inhibitors
13. 8026246 - Aurora kinase inhibitors for inhibiting mitotic progression
14. 8008307 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes
15. 7935694 - Lactam compounds useful as protein kinase inhibitors